Targeting microRNA-134 for seizure control and disease modification in epilepsy
Sign Up to like & getrecommendations! Published in 2019 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2019.07.008
Abstract: MicroRNA-134 is a brain-enriched small noncoding RNA that has been implicated in diverse neuronal functions, including regulating network excitability. Increased expression of microRNA-134 has been reported in several experimental epilepsy models and in resected brain… read more here.
Keywords: microrna 134; epilepsy; 134 seizure; disease ... See more keywords
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.20409
Abstract: Malignant mesothelioma is an aggressive and often fatal cancer associated with asbestos exposure. The disease originates in the mesothelial lining of the serosal cavities, most commonly affecting the pleura. Survival rates are low as diagnosis… read more here.
Keywords: mesothelioma; therapeutic approaches; diagnostic therapeutic; targeting microrna ... See more keywords
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.784044
Abstract: Cardiovascular diseases (CVDs) are still the main cause of morbidity and mortality worldwide and include a group of disorders varying from vasculature, myocardium, arrhythmias and cardiac development. MicroRNAs (miRs) are endogenous non-coding RNAs with 18–23… read more here.
Keywords: 34a cardiovascular; microrna 34a; cardiovascular diseases; 34a novel ... See more keywords